Cadbury India is expected to get a major foothold in the oral gratification category, thanks to the global acquisition of Pfizer’s confectionery brands. The global acquisition would help Cadbury expand its business in chewing gums and lozenges categories through Warner Lambert’s Halls, Clorets and Chiclets
In India, Cadbury’s confectionery brands include Eclairs, Gollum and Googly. While Pfizer’s confectionery business is represented through its wholly owned subsidiary Warner Lambert. The latter is in the manufacturing and marketing of confectionery products like Clorets and Halls.
Globally, Pfizer phased out its non-core business including confectionery-to-concentrate on pharmaceuticals. Recently, Pfizer clicked a deal to sell its nutrition brand Protinex to a Danish firm.
Following the global acquisition, Cadbury is expected to beef up distribution and marketing network to build back its confectionery business.
At present, Pfizer has two group companies in the country focusing on the pharma sector - Pfizer Ltd, the listed subsidiary, and Pfizer India, the wholly-owned outfit of the US parent, in addition to Warner Lambert. Another group drugs firm Parke-Davis India is being merged with Pfizer.